Get the top three things to know in women's health + wellness, every weekday:

FDA Says No More Compounded Weight Loss Drugs

What: The FDA has officially agreed that the drug shortage around GLP-1 weight loss drugs has ended, meaning the tens of thousands of Americans taking lower cost “compound” versions of the drugs (often because insurance won’t cover the brand names) will have to find another source in the coming weeks.

Key line: “The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until March 19 to stop, according to the FDA. For Wegovy, larger, national licensed facilities have until May 22, to stop making compound versions, according to the FDA.”

Source: ABC News

More News Snippets
Women’s Pain: Maybe It’s Leptin

University of Calgary researchers found that female mice release leptin, a hormone associated with heightened pain sensitivity, which may explain why women experience more pain.